Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 10.74%-6.78M | -366.25%-5.54M | -83.90%-15.04M | 22.91%-21.81M | 39.08%-4.85M | 46.03%-7.59M | 78.17%-1.19M | -899.88%-8.18M | -68.70%-28.29M | -121.41%-7.97M |
| Net income from continuing operations | -2,578.60%-64.47M | -288.59%-4.1M | 29.59%-7.17M | -186.68%-15.24M | -362.51%-4.82M | -135.28%-2.41M | -85.43%2.17M | -226.17%-10.18M | 154.05%17.58M | -101.47%-1.04M |
| Operating gains losses | 7,278.07%61.9M | -95.76%569K | -94.39%661K | 192.33%26.26M | 100.79%218K | 64.51%839K | 666.89%13.42M | 1,079.18%11.78M | -146.74%-28.44M | -2,273.60%-27.58M |
| Depreciation and amortization | -32.68%103K | -44.90%108K | -30.70%158K | -28.96%758K | -76.03%181K | 121.22%153K | -70.12%196K | -39.52%228K | 380.63%1.07M | 499.47%755K |
| Unrealized gains and losses of investment securities | 293.18%425K | 98.41%-97K | 90.74%-439K | 44.01%-12.53M | -962.79%-1.48M | 96.66%-220K | 58.44%-6.08M | -259.05%-4.74M | 49.79%-22.38M | 100.48%172K |
| Remuneration paid in stock | 26.88%3.21M | 144.71%4.05M | 229.25%4.54M | -13.93%7.23M | -70.68%1.67M | 501.59%2.53M | -24.29%1.66M | 20.14%1.38M | 614.81%8.4M | 1,388.46%5.7M |
| Deferred tax | ---1.83M | --0 | 1,907.69%1.83M | -200.00%-10.66M | --0 | --0 | ---10.75M | --91K | --10.66M | --10.66M |
| Other non cashItems | -25.29%-4.04M | -7.09%-6.86M | -23.72%-6.39M | -157.53%-21.34M | -1,408.80%-6.54M | 38.10%-3.22M | -565.21%-6.41M | -97.33%-5.16M | -5,386.75%-8.29M | 101.16%500K |
| Change In working capital | 106.38%191K | -82.81%791K | -954.15%-5.96M | 448.65%8.24M | 105.94%5.93M | 49.92%-3M | 187.79%4.6M | -88.33%698K | -152.13%-2.36M | 3.08%2.88M |
| -Change in receivables | 255.40%5.64M | 27.09%-2.55M | 66.34%-2.59M | -1,516.70%-16.46M | -10.20%-1.63M | -208.23%-3.63M | -27.40%-3.49M | -5,106.76%-7.71M | -681.71%-1.02M | -262.21%-1.48M |
| -Change in prepaid assets | --0 | --0 | --0 | 199.95%4.35M | --0 | --0 | --0 | --4.35M | ---4.35M | ---- |
| -Change in payables and accrued expense | -961.87%-5.45M | -58.77%3.34M | -183.10%-3.37M | 576.04%20.34M | -13.21%7.56M | 104.79%632K | 495.15%8.09M | -33.89%4.05M | -30.92%3.01M | 363.26%8.71M |
| Interest paid (cash flow from operating activities) | 0.00%-2.26M | --0 | 0.00%-2.26M | 0.00%-4.53M | --0 | 0.00%-2.26M | --0 | 0.00%-2.26M | 28.09%-4.53M | --0 |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | 36.68%-30.68M | 27.38%-7.05M | |||
| Operating cash flow | 10.74%-6.78M | -366.25%-5.54M | -83.90%-15.04M | 63.01%-21.81M | 67.69%-4.85M | 41.76%-7.59M | 90.01%-1.19M | 57.01%-8.18M | 9.59%-58.97M | -5.07%-15.02M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 104.49%2.95M | -102.21%-227K | 113.03%3.67M | -210.50%-85.86M | -15.28%-2.22M | -232.83%-65.76M | 329.61%10.25M | -181.34%-28.13M | 136.90%77.7M | -108.70%-1.92M |
| Net PPE purchase and sale | 6,502.13%3.01M | 73.05%-200K | 96.28%-29K | 78.74%-1.67M | 93.45%-105K | 98.01%-47K | 61.53%-742K | 60.46%-779K | -479.81%-7.87M | -2,866.67%-1.6M |
| Net business purchase and sale | ---58K | -106.31%-27K | 47.20%-226K | 22.46%-3.68M | -97.69%-3.68M | --0 | 122.81%428K | 40.22%-428K | -118.65%-4.75M | -113.20%-1.86M |
| Net investment purchase and sale | --0 | ---- | ---- | --0 | 1.88%1.57M | -101.30%-712K | -103.60%-858K | --0 | 200.00%155M | -97.01%1.54M |
| Net other investing changes | --0 | --0 | 114.56%3.92M | -24.46%-80.5M | --0 | -2,553.02%-65M | 146.62%11.42M | 28.64%-26.93M | 18.82%-64.68M | --0 |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | -474.82%-116.8M | 0 | |||
| Investing cash flow | 104.49%2.95M | -102.21%-227K | 113.03%3.67M | -119.57%-85.86M | -15.28%-2.22M | -555.48%-65.76M | 119.73%10.25M | -213.39%-28.13M | 83.06%-39.1M | -108.84%-1.92M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.11%-76K | 68.84%-62K | 54.96%-118K | 123.66%68.77M | 99.99%-42K | 25,018.71%69.27M | 30.66%-199K | -160.37%-262K | -1,158.65%-290.64M | -397,852.05%-290.51M |
| Net issuance payments of debt | 72.06%-76K | 68.84%-62K | 54.96%-118K | -328.99%-774K | 86.69%-41K | -141.53%-272K | ---199K | ---262K | 101.35%338K | -1.65%-308K |
| Net common stock issuance | ---- | ---- | ---- | --70M | --0 | ---- | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -91.04%172K | --15K |
| Net other financing activities | ---- | ---- | ---- | 99.84%-455K | 100.00%-1K | ---- | ---- | -194.24%-262K | ---291.15M | ---290.21M |
| Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 81,050.53%302.76M | 0 | |||
| Financing cash flow | -100.11%-76K | 68.84%-62K | 54.96%-118K | 467.46%68.77M | 99.99%-42K | 17,771.94%69.27M | 98.84%-199K | -100.08%-262K | 151.65%12.12M | -129,590.63%-290.51M |
| Net cash flow | ||||||||||
| Beginning cash position | -29.28%68.03M | -14.23%73.94M | -30.05%85.54M | -37.12%122.29M | -37.37%92.33M | -78.38%96.2M | -83.49%86.2M | -37.12%122.29M | -61.91%194.47M | -20.56%147.41M |
| Current changes in cash | 4.27%-3.9M | -165.76%-5.83M | 68.57%-11.49M | 54.75%-38.9M | 97.69%-7.11M | 82.63%-4.08M | 110.93%8.86M | -111.22%-36.57M | 73.10%-85.95M | -4,342.42%-307.45M |
| Effect of exchange rate changes | -163.24%-129K | -107.05%-80K | -123.59%-113K | -84.41%2.15M | -95.17%330K | -84.65%204K | -71.88%1.13M | -69.72%479K | 301.22%13.77M | 309.96%6.83M |
| End cash Position | -30.68%64M | -29.28%68.03M | -14.23%73.94M | -30.05%85.54M | -30.05%85.54M | -37.37%92.33M | -78.38%96.2M | -83.49%86.2M | -37.12%122.29M | -37.12%122.29M |
| Free cash from | 11.29%-6.78M | -197.36%-5.74M | -68.23%-15.07M | 64.87%-23.48M | 70.17%-4.96M | 50.40%-7.64M | 86.04%-1.93M | 57.34%-8.96M | -0.39%-66.84M | -15.84%-16.62M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.